Skip to main content

Table 2 Maximum grade toxicities per patient

From: A Korean single-center, real-world, retrospective study of first-line weekly paclitaxel in patients with metastatic angiosarcoma

 

All grades, N (%)

Grades 3 or 4, N (%)

Anemia

5 (24 %)

2 (10 %)

Neutropenia

3 (14 %)

2 (10 %)

Thrombocytopenia

1 (5 %)

0

Infection

1 (5 %)

1 (5 %)

Nausea and vomiting

13 (62 %)

1 (5 %)

Anorexia

10 (48 %)

 

Stomatitis

6 (29 %)

0

Diarrhea

4 (19 %)

0

Fatigue

10 (48 %)

0

Peripheral neuropathy

14 (67 %)

0

Allergic reaction

2 (10 %)

0